Moleculin Biotech, Inc.

US$8.70As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MBRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (62.28%)
Div yield —
ROE (1371.64%)
Biotechnology
Beta (5Y) 2.09
PE TTM —
TSR TTM (96.26%)
Mkt cap US$8.473M
ROIC (703.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.95
14.32%
(16.28%)
Hold 11|6|2|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.12
0.11
14.44%
5.34%
9.83%
3.90%
Revenue$M
0.615
0.614
0.651
0.637
17.33%
12.32%
12.37%
8.37%
Peers (US$8.473M)
Cap (US$)
PE
9.134M
—
7.975M
—
Capital
TTM
5Y
10Y
Leveragex
0.202
0.015
0.017
EBIT/Intx
0.596
0.119
0.164
Own earn%
124.49
(89.79)
(73.44)
Sh yield%
29.23
18.28
17.27
Owners
Insiders/Inst%
12.22
52.71
Short interest%
1.40
SBC / revenue%
5.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
30–36
$1 testx
—
Incr. ROIC%
5